546 related articles for article (PubMed ID: 20463974)
21. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
Jarius S; Jacobi C; de Seze J; Zephir H; Paul F; Franciotta D; Rommer P; Mader S; Kleiter I; Reindl M; Akman-Demir G; Seifert-Held T; Kristoferitsch W; Melms A; Wandinger KP; Wildemann B
Mult Scler; 2011 Sep; 17(9):1067-73. PubMed ID: 21543553
[TBL] [Abstract][Full Text] [Related]
22. Neuromyelitis optica pathogenesis and aquaporin 4.
Graber DJ; Levy M; Kerr D; Wade WF
J Neuroinflammation; 2008 May; 5():22. PubMed ID: 18510734
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
24. The role of aquaporin-4 antibodies in Chinese patients with neuromyelitis optica.
Yang Y; Huang DH; Wu WP; Wu L; Chen LF; Wu Q
J Clin Neurosci; 2013 Jan; 20(1):94-8. PubMed ID: 23142234
[TBL] [Abstract][Full Text] [Related]
25. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
26. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.
Kim W; Lee JE; Li XF; Kim SH; Han BG; Lee BI; Kim JK; Choi K; Kim HJ
Mult Scler; 2012 May; 18(5):578-86. PubMed ID: 21965418
[TBL] [Abstract][Full Text] [Related]
27. Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG.
Owens GP; Ritchie A; Rossi A; Schaller K; Wemlinger S; Schumann H; Shearer A; Verkman AS; Bennett JL
J Biol Chem; 2015 May; 290(19):12123-34. PubMed ID: 25792738
[TBL] [Abstract][Full Text] [Related]
28. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.
Kim YJ; Jung SW; Kim Y; Park YJ; Han K; Oh EJ
J Clin Lab Anal; 2012 May; 26(3):184-9. PubMed ID: 22628234
[TBL] [Abstract][Full Text] [Related]
29. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
30. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
[TBL] [Abstract][Full Text] [Related]
31. Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificity.
Pisani F; Sparaneo A; Tortorella C; Ruggieri M; Trojano M; Mola MG; Nicchia GP; Frigeri A; Svelto M
PLoS One; 2013; 8(11):e79185. PubMed ID: 24260168
[TBL] [Abstract][Full Text] [Related]
32. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
Waters P; Jarius S; Littleton E; Leite MI; Jacob S; Gray B; Geraldes R; Vale T; Jacob A; Palace J; Maxwell S; Beeson D; Vincent A
Arch Neurol; 2008 Jul; 65(7):913-9. PubMed ID: 18625857
[TBL] [Abstract][Full Text] [Related]
33. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.
Jarius S; Probst C; Borowski K; Franciotta D; Wildemann B; Stoecker W; Wandinger KP
J Neurol Sci; 2010 Apr; 291(1-2):52-6. PubMed ID: 20117794
[TBL] [Abstract][Full Text] [Related]
34. Neuromyelitis Optica Immunoglobulin G present in sera from neuromyelitis optica patients affects aquaporin-4 expression and water permeability of the astrocyte plasma membrane.
Melamud L; Fernández JM; Rivarola V; Di Giusto G; Ford P; Villa A; Capurro C
J Neurosci Res; 2012 Jun; 90(6):1240-8. PubMed ID: 22354518
[TBL] [Abstract][Full Text] [Related]
35. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
Kira J
Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
[TBL] [Abstract][Full Text] [Related]
36. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
Kinoshita M; Nakatsuji Y; Kimura T; Moriya M; Takata K; Okuno T; Kumanogoh A; Kajiyama K; Yoshikawa H; Sakoda S
Biochem Biophys Res Commun; 2009 Sep; 386(4):623-7. PubMed ID: 19545538
[TBL] [Abstract][Full Text] [Related]
37. Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays.
Iorio R; Fryer JP; Hinson SR; Fallier-Becker P; Wolburg H; Pittock SJ; Lennon VA
J Autoimmun; 2013 Feb; 40():21-7. PubMed ID: 22906356
[TBL] [Abstract][Full Text] [Related]
38. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
Jarius S; Aboul-Enein F; Waters P; Kuenz B; Hauser A; Berger T; Lang W; Reindl M; Vincent A; Kristoferitsch W
Brain; 2008 Nov; 131(Pt 11):3072-80. PubMed ID: 18945724
[TBL] [Abstract][Full Text] [Related]
39. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
[TBL] [Abstract][Full Text] [Related]
40. Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China.
Yang CS; Zhang DQ; Wang JH; Jin WN; Li MS; Liu J; Zhang CJ; Li T; Shi FD; Yang L
CNS Neurosci Ther; 2014 Jan; 20(1):32-9. PubMed ID: 23890015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
